Practice Tips

CMA to launch fact-finding mission on European health-care reform

Dr. Robert Ouellet, president of the CMA, today announced the CMA's intention to begin an international fact-finding mission examining ideas for health care reform and renewal in several European countries.
Voltaren Emulgel: nonprescription topical NSAID

Novartis Consumer Healthcare is introducing the first nonprescription topical nonsteroidal anti-inflammatory drug to be marketed in Canada.
Head lice: updated statement

The Canadian Paediatric Society has issued a revised statement on the diagnosis and management of head lice.
Revlimid approved for multiple myeloma

Celgene's Revlimid (lenalidomide 15 mg and 25 mg capsules) is now indicated for the treatment of multiple myeloma (in combination with dexamethasone) in patients who have received at least one prior therapy.
Spotlight: Lighting a spark in the profession

Susan Beresford juggles involvement in six professional bodies, in addition to her full-time job as dispensary manager.
Practice Issues: Adverse reactions - ACEI- and ARB-induced angioedema

Angioedema is a self-limiting, nonpitting edema that occurs in the skin and mucous membranes.
A Question of Ethics

Can pharmacy accommodate differing principles?
Ont. survey shows painkiller addiction growing concern

Team-based approach to treatment could help.

Canadian statement on PPIs and hip fracture